Avoiding “Loss of Chance”… Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

Provider Statement: This continuing medical education activity is provided by .

Support Statement: This activity is supported by an educational grant from Genentech, Inc.

Target Audience: The intended audience for this activity is endocrinologists, diabetologists, diabetes educators, nurse practitioners, and other health care professionals involved in the treatment of patients with diabetic retinopathy.

Learning Objectives: Upon successful completion of the activities, participants should be better able to:

• Examine the pathophysiology behind diabetic retinopathy to better comprehend how treatment may improve vision loss.
• Employ current screening and referral guidelines pertaining to diabetic retinopathy to assist in the prevention of visual loss in patients with diabetes.
• Assess the use of imaging in the diagnostic evaluation of patients with diabetes.
• Compare current treatment options for diabetic retinopathy for their safety, efficacy, and ability to improve visual acuity.

Activity Co-Chairs:
Rishi P. Singh, MD
Staff Physician, Cole Eye Institute
Medical Director, Clinical Systems Office
Assistant Professor of Ophthalmology
Case Western Reserve University
Cleveland, OH

Vivian A. Fonseca, MD, FRCP
Professor of Medicine and Pharmacology
Tullis–Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

Faculty: 
Sangeeta R. Kashyap, MD
Associate Professor Medicine
Cleveland Clinic Lerner College of Medicine
Department of  Endocrinology, Diabetes and Metabolism
Cleveland, OH

Jennifer K. Sun, MD, MPH
Assistant Professor, Department of Ophthalmology
Harvard Medical School
Chief, Center for Clinical Eye Research and Trials
Beetham Eye Institute
Boston, MA

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners participating in activities can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

This enduring material is approved for 1 year from the date of original release, September 1, 2015, through September 1, 2016.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the articles, complete the CME posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 7 out of 10 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control

Planning Committee and Faculty members report the following relationship(s):
Rishi P. Singh, MD
Consulting Fees: Alcon, Genentech, Regeneron, ThromboGenics
Speakers Bureau: Genentech, Regeneron, ThromboGenics
Ownership Interest: Ophthotech

Vivian A. Fonseca, MD, FRCP
Contracted Research (paid to institution): Abbott, Asahi, Eli Lilly, Endo Barrier, Gilead Sciences, Novo Nordisk  
Consulting Fee: Abbott, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Novo Nordisk, Pamlab, Sanofi-Aventis, Takeda
Speakers Bureau: Abbott, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Novo Nordisk, Pamlab, Sanofi-Aventis, Takeda

Sangeeta R. Kashyap, MD
Contracted Research: Covidien, Ethicon

Jennifer K. Sun, MD, MPH
Consulting Fee: Allergan, Kowa, Regeneron
Contracted Research: Boston Micromachines, Genentech, Optovue

Medical Writer reports the following relationship(s):
Michelle Dalton, ELS
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?
Contact us at cme@vindicoCME.com